C
Cytomx Therapeutics (CTMX)
$000.00 0.00% ($0.00)
- Today
- Week
- Month
- Year
- 5 Year
- YTD
getbaraka.com
About Cytomx Therapeutics (CTMX)
CytomX Therapeutics, Inc. is a clinical-stage, oncology-focused biopharmaceutical company. The Company uses its Probody technology platform to create cancer immunotherapies against clinically validated targets, as well as to develop cancer therapeuti... Read more
- USD0.96
- USD1.00
- USD0.92
- USD4.21
- 112.10%
- 138M
- 2.04M
- 1.52M
- 65M
- 0.40
- -77.90%
- 7.00%
Stock News
43 minutes ago
Costco managed another month of sales growth in April. But it marks a slowdown from March.
MarketWatch
49 minutes ago
Alphabet’s stock is sliding on AI fears. Are investors overreacting?
MarketWatch
2 hours ago
Fed keeps rates steady — plus, Apple's search revelation and our new DuPont price target
CNBC
2 hours ago
Who is Berkshire Hathaway's Greg Abel? Warren Buffett explained his choice of successor: 'He understands businesses extremely well'
CNBC
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
